Showing 4171-4180 of 5623 results for "".
- Shamir Announces Changes in Executive Leadershiphttps://modernod.com/news/shamir-announces-changes-in-executive-leadership/2480772/Shamir Insight announced that effective April 1, 2022, Pierson Ball, the company’s Director of Business and Strategic Development has been appointed as the new Vice President of Sales. Mr. Ball joined Shamir in 2007. “I am proud to have been part of the development and
- Ultrasound Gave Us Our First Baby Pictures. Can It Also Help the Blind See?https://modernod.com/news/ultrasound-gave-us-our-first-baby-pictures-can-it-also-help-the-blind-see/2480771/The number of Americans with visual impairment or blindness is expected to jump to more than 8 million by the year 2050,
- Lumibird Medical Launches Nd:YAG Laser Capsulohttps://modernod.com/news/lumibird-medical-launches-new-ndyag-laser-capsulo/2480767/Lumibird Group, the parent company of Quantel Medical, announced the launch of the Capsulo Nd:YAG laser. Lumibird says the device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments. &ld
- Study: People with Vision Impairments up to Four Times More Likely to Suffer Mental Health Problemshttps://modernod.com/news/study-people-with-vision-impairments-up-to-four-times-more-likely-to-suffer-mental-health-problems/2480757/Research by international development organization Sightsavers, University of Ilorin, and the Kogi State Ministry of Health, in Nigeria has revealed links between vision impairment and poor mental health.
- Zeiss to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software Applicationshttps://modernod.com/news/zeiss-to-unveil-clinical-insights-supporting-the-value-of-new-data-driven-digital-workflow-solutions-and-software-applications/2480752/Zeiss Medical Technology will host ZEISS Innovation Day on April 7, 2022, showcasing clinical perspectives from global experts with first-hand experience integrating devices, data and software applications.
- Amydis Appoints Robert N. Weinreb, MD, as First Chair of Scientific Advisory Boardhttps://modernod.com/news/amydis-appoints-robert-n-weinreb-md-as-first-chair-of-scientific-advisory-board/2480742/Amydis announced the appointment of clinician scientist, Robert N. Weinreb, MD, as the First Chair to the Scientific Advisory Board of the company. “Amydis is at the forefront of developing compounds that enable retinal imaging of molecula
- Researchers Generate First Complete, Gapless Sequence of a Human Genomehttps://modernod.com/news/researchers-generate-first-complete-gapless-sequence-of-a-human-genome/2480741/Scientists have published the first complete, gapless sequence of a human genome, two decades after the Human Genome Project produced the first draft human genome sequence, according to the National Institutes of Health. According to researchers, having a complete, gap-free sequen
- Outlook Therapeutics Submits Biologics License Application to the FDA for ONS-5010 as a Treatment for Wet AMDhttps://modernod.com/news/outlook-therapeutics-submits-biologics-license-application-to-the-fda-for-ons-5010-as-a-treatment-for-wet-amd/2480738/Outlook Therapeutics announced it has submitted its biologics license application (BLA) to the FDA for ONS-5010, an investigational therapy which, if approved, will be branded as Lytenava (bevacizumab-vikg), for the treatment of wet age-related macular degeneration (AMD).&nbs
- Study: Dry Eye Disease Signs and Symptoms Significantly Reduced with Ciclosporin A 0.1% Cationic Emulsionhttps://modernod.com/news/study-dry-eye-disease-signs-and-symptoms-significantly-reduced-with-ciclosporin-a-01-cationic-emulsion/2480734/Santen EMEA has announced the results of PERSPECTIVE, a real-world evidence study evaluating the long-term treatment of severe keratitis in adult dry eye disease (DED) patients. The study, which was conducted across 44 ophthalmology clinics in 5 European countries, demonstrated that ciclosporin A
- Graybug Updates its Ophthalmic Pipeline Programshttps://modernod.com/news/graybug-updates-its-ophthalmic-pipeline-programs/2480733/Graybug Vision announced a strategic update on its pipeline programs GB-102 in wet age-related macular degeneration (AMD); GB-401, in primary open-angle glaucoma (POAG); as well as its newly acquired assets in corneal disease (GB-501); inherited retinal diseases (GB-601); and